The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm
Open accessAbstract
Automated immunoassays used to evaluate thyroid function are vulnerable to different types of interference that can affect clinical decisions. This review provides a detailed overview of the six main types of interference known to affect measurements of thyroid stimulating hormone (TSH), free thyroxine (T4) and free triiodothyronine (T3): macro-TSH, biotin, antistreptavidin antibodies, anti-ruthenium antibodies, thyroid hormone autoantibodies, and heterophilic antibodies. Because the prevalence of some of these conditions has been reported to approach 1% and the frequency of testing for thyroid dysfunction is important, the scale of the problem might be tremendous. Potential interferences in thyroid function testing should always be suspected whenever clinical or biochemical discrepancies arise. Their identification usually relies on additional laboratory tests, including assay method comparison, dilution procedures, blocking reagents studies, and polyethylene glycol precipitation. Based on the pattern of thyroid function test alterations, to screen for the six aforementioned types of interference, we propose a detection algorithm, which should facilitate their identification in clinical practice. The review also evaluates the clinical impact of thyroid interference on immunoassays. On review of reported data from more than 150 patients, we found that ≥50% of documented thyroid interferences led to misdiagnosis and/or inappropriate management, including prescription of an unnecessary treatment (with adverse effects in some situations), inappropriate suppression or modification of an ongoing treatment, or use of unnecessary complementary tests such as an I123 thyroid scan. Strong interaction between the clinician and the laboratory is necessary to avoid such pitfalls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“interference from heterophilic antibodies can result in both low and high measures, with elevated values being more common.”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Rarely, more extreme analytical errors are present137 (Table 5).”
In the citing paper
“A number of medications can affect the thyroid function tests not only by interfering with the synthesis, transport, and metabolism of TSH and thyroid hormones but also by interfering with thyroid function immunoassays (30, 37–40) ( Table 1 ).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [38]
In the citing paper
“Furthermore, assay variability, potential interference with rheumatoid factors or heterophilic antibodies, occasional cases of macro-TSH, the observed age related shift towards higher TSH concentrations in older iodine sufficient patients, and obesity may affect this population based sample to an extent.45 46 47 48”
From Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study (2019) · cites this paper as [45]
In the citing paper
“It is worth highlighting that whilst immunoassay platforms are currently the method of choice for the measurement of thyroid function tests [116], there are limitations; as well as macro-TSH, interference from biotin, thyroid hormone autoantibodies, heterophilic antibodies, antistreptavidin antibodies, anti-ruthenium antibodies, and heterophilic antibodies can occur [116].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [116]
In the citing paper
“It is worth highlighting that whilst immunoassay platforms are currently the method of choice for the measurement of thyroid function tests [116], there are limitations; as well as macro-TSH, interference from biotin, thyroid hormone autoantibodies, heterophilic antibodies, antistreptavidin antibodies, anti-ruthenium antibodies, and heterophilic antibodies can occur [116].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [116]
In the citing paper
“Low free T4 combined with inappropriately low or normal TSH is also frequent in several other situations where treatment is not required, e.g.due to heterophilic antibodies or other interfering factors in the serum of the patient/person under study (Favresse et al., 2018).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Favresse et al., 2018
In the citing paper
“Biotin, antistreptavidin antibodies, antiruthenium antibodies, and thyroid hormone autoantibodies provide other sources of interference with the TSH test that may lead to an aberrant result [36].”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [36]
In the citing paper
“Immunoassay platforms can be susceptible to interferences, potentially leading to incorrect clinical decisions.”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
In the citing paper
“Suspecting macro-TSH interference is advised with isolated TSH elevation (typically higher than 10 mUI/L) and thyroid hormones within the upper normal range, without clinical evidence of thyroid dysfunction.”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
In the citing paper
“Anti-T4 and anti-T3 autoantibodies, found in 40% of autoimmune thyroid disease cases, can lead to false hormone elevations”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
In the citing paper
“Biotin (in doses higher than 1.5 mg/d) can cause falsely low TSH levels and elevated fT4 and fT3, with its impact depending on the platform used, and being avoided with a washout period.”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fundamentals of Clinical Chemistry.
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-1-142_1 · Cited by 2,624
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Tietz Fundamentals of Clinical Chemistry
Burtis, E. B. C. A., & Ashwood, E. R. (1996) · Cited by 919
The biotin-(strept)avidin system: principles and applications in biotechnology
Diamandis, E. P., & Christopoulos, T. K. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.5.625 · Cited by 748
Human Anti-Animal Antibody Interferences in Immunological Assays
Kricka, L. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.942 · Cited by 581
Tate, J. R., & Ward, G. (2004) · PubMed · Cited by 426
Park, J. Y., & Kricka, L. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-08-097037-0.00027-0 · Cited by 372
The thyroxine-binding proteins
Schussler, G. C. (2000) · Thyroid · doi:10.1089/thy.2000.10.141 · Cited by 329
Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men
Blumeyer, A., Tosti, A., Messenger, A. G., Reygagne, P., del Mármol, V., Spuls, P. I., Trakatelli, M. G., Finner, A. M., Kiesewetter, F., Trüeb, R. M., et al. (2011) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0379.2011.07802.x · Cited by 304
Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Persani, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1616 · Cited by 295
Pitfalls in the measurement and interpretation of thyroid function tests
Koulouri, O., Moran, C., Halsall, D., Chatterjee, K., & Gurnell, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.003 · Cited by 282
Antibody interference in thyroid assays: a potential for clinical misinformation
Després, N., & Grant, A. M. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.3.440 · Cited by 262
Levinson, S. S., & Miller, J. J. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00275-9 · Cited by 238
Heterophilic antibody interference in immunometric assays
Bolstad, N., Warren, D. J., & Nustad, K. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.011 · Cited by 238
High doses of biotin in chronic progressive multiple sclerosis: A pilot study
Sedel, F., Papeix, C., Bellanger, A., Touitou, V., Lebrun‐Frénay, C., Galanaud, D., Gout, O., Lyon‐Caen, O., & Tourbah, A. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.01.005 · Cited by 230
B IOTIN IN M ETABOLISM AND M OLECULAR B IOLOGY
McMahon, R. J. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.121101.112819 · Cited by 183
Leslie, H., Courtney, C. H., Bell, P. M., Hadden, D. R., McCance, D. R., Ellis, P. K., Sheridan, B., & Atkinson, A. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7521 · Cited by 177
Autoantibodies Against Thyroid Hormones or lodothyronine
Sakata, S., NAKAMURA, S., & MIURA, K. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-579 · Cited by 174
The investigation of interferences in immunoassay
Ward, G., Simpson, A. J., Boscato, L., & Hickman, P. E. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.08.015 · Cited by 155
Ismail, A. A., Walker, P. L., Barth, J. H., Lewandowski, K. C., Jones, R., & Burr, W. A. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.11.2023 · Cited by 149
Inherited Thyroxine-Binding Globulin Abnormalities in Man*
Refetoff, S. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-275 · Cited by 146
Interference in immunoassay is an underestimated problem
Ismail, A., Walker, P., Cawood, M., & Barth, J. (2002) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456302760042128 · Cited by 144
Determination of prolactin: The macroprolactin problem
Fahie‐Wilson, M. N., & Smith, T. P. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.07.002 · Cited by 143
Inherited defects of thyroxine-binding proteins
Pappa, T., Ferrara, A. M., & Refetoff, S. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.09.002 · Cited by 139
Kaplan, I. V., & Levinson, S. S. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.5.616 · Cited by 138
Piketty, M., Prié, D., Sedel, F., Bernard, D., Hercend, C., Chanson, P., & Souberbielle, J. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-1183 · Cited by 138
Macroprolactin; high molecular mass forms of circulating prolactin
Fahie‐Wilson, M. N., John, R., & Ellis, A. R. (2005) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563053857969 · Cited by 135
Beltran, L., Fahie‐Wilson, M. N., McKenna, T. J., Kavanagh, L., & Smith, T. P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105312 · Cited by 135
Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults
Li, D., Radulescu, A., Shrestha, R. T., Root, M., Karger, A. B., Killeen, A. A., Hodges, J. S., Fan, S.-L., Ferguson, A. M., Garg, U. C., et al. (2017) · JAMA · doi:10.1001/jama.2017.13705 · Cited by 132
Immunometric Assay Interference
Bjerner, J., Nustad, K., Norum, L. F., Olsen, K. H., & Børmer, O. P. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.4.613 · Cited by 128
Elston, M. S., Sehgal, S., Toit, S. D., Yarndley, T., & Conaglen, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1971 · Cited by 127
Biotin Treatment Mimicking Graves’ Disease
Kummer, S., Hermsen, D. F., & Distelmaier, F. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1602096 · Cited by 120
Specificity and Clinical Utility of Methods for the Detection of Macroprolactin
Kavanagh, L., McKenna, T. J., Fahie‐Wilson, M. N., Gibney, J., & Smith, T. P. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.065854 · Cited by 118
Piketty, M., Polak, M., Flechtner, I., Gonzales-Briceño, L., & Souberbielle, J. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0606 · Cited by 118
AN UNUSUAL INSTANCE OF THYROXINE-BINDING BY HUMAN SERUM GAMMA GLOBULIN*
ROBBINS, J. J., Rall, J. E., & Rawson, R. W. (1956) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-16-5-573 · Cited by 113
Macroprolactinemia: Diagnostic, Clinical, and Pathogenic Significance
Shimatsu, A., & Hattori, N. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/167132 · Cited by 108
Biotin-responsive basal ganglia disease revisited
Tabarki, B. M., Alshafi, S., AlShahwan, S., Azmat, Z., Alhashem, A. M., Al-Adwani, N., Biary, N. M., Alzawahmah, M., Khan, S., & Zuccoli, G. (2012) · Neurology · doi:10.1212/wnl.0b013e31827deb4c · Cited by 107
Barbesino, G. (2016) · Thyroid® · doi:10.1089/thy.2015.0664 · Cited by 105
Laboratory Medicine Practice Guidelines
(2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-4037 · Cited by 102
Thienpont, L. M., Van Uytfanghe, K., De Grande, L. A. C., Reynders, D., Das, B., Faix, J. D., MacKenzie, F., Decallonne, B., Hishinuma, A., Lapauw, B., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.269456 · Cited by 101
Lippi, G., Aloe, R., Meschi, T., Borghi, L., & Cervellin, G. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.09.004 · Cited by 95
JAUME, J. C., MENDEL, C. M., FROST, P. H., GREENSPAN, F. S., & LAUGHTON, C. W. (1996) · Thyroid · doi:10.1089/thy.1996.6.79 · Cited by 92
What should be done when thyroid function tests do not make sense?: Atypical thyroid function tests
Gurnell, M., Halsall, D. J., & Chatterjee, V. K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04023.x · Cited by 88
Macro-Thyrotropin: A Case Report and Review of Literature
Loh, T. P., Kao, S. L., Halsall, D. J., Toh, S.-A. E. S., Chan, E., Ho, S. C., Tai, E. S., & Khoo, C. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3490 · Cited by 84
Wijeratne, N. G., Doery, J. C. G., & Lu, Z. X. (2012) · Pathology · doi:10.1097/pat.0b013e32835a3c17 · Cited by 84
Stockigt, J. R., & Lim, C.-F. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.004 · Cited by 79
Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know
Ismail, A. A. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.055848 · Cited by 76
Prevalence of thyroid hormone autoantibodies in healthy subjects
Sakata, S., Matsuda, M., Ogawa, T., Takuno, H., Matsul, I., Sarui, H., & Yasuda, K. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02558.x · Cited by 76
Falsely Elevated Thyroid-Stimulating Hormone (TSH) Level Due to Macro-TSH
Sakai, H., Fukuda, G., Suzuki, N., WATANABE, C., & Odawara, M. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-361 · Cited by 74
Biotin interference on TSH and free thyroid hormone measurement
Kwok, J. S.-S., Chan, I. H.-S., & Chan, M. H.-M. (2012) · Pathology · doi:10.1097/pat.0b013e3283514002 · Cited by 74
Influence of Heparin on Serum Free Thyroxine1
Schatz, D. L., Sheppard, R. H., Steiner, G. A., CHANDARLAPATY, C. S., & deVeber, G. A. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-8-1015 · Cited by 73
Macro TSH in patients with subclinical hypothyroidism
Hattori, N., Ishihara, T., Yamagami, K., & Shimatsu, A. (2014) · Clinical Endocrinology · doi:10.1111/cen.12643 · Cited by 73
Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers
Hattori, N., Ishihara, T., & Saiki, Y. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03570.x · Cited by 69
Trambas, C., Lu, Z. X., Yen, T., & Sikaris, K. A. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217707783 · Cited by 67
Interference From Anti-Streptavidin Antibody
Rulander, N. J., Cardamone, D., Senior, M. B., Snyder, P. J., & Master, S. R. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0270-cr · Cited by 63
Samson, S., Hamrahian, A. H., & Ezzat, S. (2015) · Endocrine Practice · doi:10.4158/ep15938.dsc · Cited by 62
Czernichow, P., Vandalem, J. L., & Hennen, G. P. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-2-387 · Cited by 59
Sapin, R., & Schlienger, J.-L. (2003) · PubMed · Cited by 59
Familial Dysalbuminemic Hyperthyroxinemia: A Persistent Diagnostic Challenge
Cartwright, D., O’Shea, P. M., Rajanayagam, O., Agostini, M., Barker, P., Moran, C., Macchia, E., Pinchera, A., John, R., Agha, A., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.120303 · Cited by 59
A Case With Immunoassay Interferences in the Measurement of Multiple Hormones
Gülbahar, Ö., Değertekin, C. K., Aktürk, M., Yalçın, M. M., Sarı, I. K., Atikeler, G., Altınova, A. E., Yetkin, İ., Arslan, M., & Törüner, F. B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4023 · Cited by 58
Directional thyroid hormone distribution via the blood stream to target sites
Janssen, S. T., & Janssen, O. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.037 · Cited by 58
Variability in the detection of macro TSH in different immunoassay systems
Hattori, N., Ishihara, T., & Shimatsu, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0883 · Cited by 57
SENSITIVE TEST FOR THYROID HORMONE AUTOANTIBODIES IN SERUM
Allan, D. J., Murphy, F., Needham, C. A., Barron, N. P., Wilkins, T. A., & Midgley, J. E. M. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92716-7 · Cited by 55
Henry, J., Sobki, S. H., & Arafat, N. (1996) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329603300214 · Cited by 54
De Grande, L. A. C., Van Uytfanghe, K., Reynders, D., Das, B., Faix, J. D., MacKenzie, F., Decallonne, B., Hishinuma, A., Lapauw, B., Taelman, P., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.274407 · Cited by 54
Mills, F., Jeffery, J., Mackenzie, P., Cranfield, A., & Ayling, R. M. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213476271 · Cited by 53
Minkovsky, A., Lee, M. N., Dowlatshahi, M., Angell, T. E., Mahrokhian, L. S., Petrides, A. K., Melanson, S. E. F., Marqusee, E., & Woodmansee, W. W. (2016) · AACE Clinical Case Reports · doi:10.4158/ep161261.cr · Cited by 52
On detecting interference from endogenous antibodies in immunoassays by doubling dilutions test
Ismail, A. A. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.152 · Cited by 49
Increased High-Molecular-Weight Thyrotropin with Impaired Biologic Activity in a Euthyroid Man
Spitz, I. M., Roith, D. L., Hirsch, H. J., Carayon, P., Pekonen, F., Liel, Y., Sobel, R., Chorer, Z., & Weintraub, B. D. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101293040506 · Cited by 49
Biotin Interference in Clinical Immunoassays: A Cause for Concern
HOLMES, E. W., Samarasinghe, S., Emanuele, M. A., & Meah, F. A. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0107-le · Cited by 49
Erroneous laboratory results: what clinicians need to know
Ismail, Y., Ismail, A., & Ismail, A. A. (2007) · Clinical Medicine · doi:10.7861/clinmedicine.7-4-357 · Cited by 47
Kahn, B. B., Weintraub, B. D., Csákó, G., & ZWEIG, M. H. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-526 · Cited by 46
Gendrel, D., Feinstein, M.-C., Grenier, J., Roger, M., Ingrand, J., Chaussain, J., Canlorbe, P., & Job, J. C. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-1-62 · Cited by 46
Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies
Fiad, T. M., Duffy, J., & McKenna, T. J. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02563.x · Cited by 45
More on Biotin Treatment Mimicking Graves’ Disease
Kummer, S., Hermsen, D., & Distelmaier, F. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1611875 · Cited by 45
A Case of Renal Osteodystrophy with Unexpected Serum Intact Parathyroid Hormone Concentrations
Meany, D. L., de Beur, S. M. J., Bill, M. J., & Sokoll, L. J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.121921 · Cited by 43
Halsall, D. J., Fahie‐Wilson, M. N., Hall, S. K., Barker, P., Anderson, J. M., Gama, R. M., & Chatterjee, K. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.071050 · Cited by 43
Willeman, T., Casez, O., Faure, P., & Gauchez, A. S. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0980 · Cited by 43
John, R., Henley, R., & Shankland, D. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.3.470 · Cited by 42
Kragh‐Hansen, U., Galliano, M., & Minchiotti, L. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00297 · Cited by 39
False Hyperthyrotropinemia Induced by Heterophilic Antibodies against Rabbit Serum
SCHAISON, G., THOMOPOULOS, P., Moulias, R., & Feinstein, M. C. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-200 · Cited by 37
Batista, M. C., Ferreira, C. E. S., Faulhaber, A. C. L., Hidal, J. T., Lottenberg, S. A., & Mangueira, C. L. P. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0628 · Cited by 37
Influence of Thyroid Hormone Autoantibodies on 7 Thyroid Hormone Assays
Zouwail, S., O’Toole, A. M., CLARK, P. M. S., & Begley, J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.099770 · Cited by 36
Heterophilic Serum Antibodies: A Cause for Falsely Elevated Serum Thyrotropin Levels
BRENNAN, M. D., Klee, G. G., Preissner, C. M., & HAY, I. D. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65044-7 · Cited by 35
Interference from heterophilic antibodies in seven current TSH assays
Ross, H. A., Menheere, P. P. C. A., Thomas, C. M. G., Mudde, A. H., Kouwenberg, M., & Wolffenbuttel, B. H. R. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008066 · Cited by 34
Rix, M., Laurberg, P., Porzig, C., & Kristensen, S. R. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02212.x · Cited by 33
Interference by antiruthenium antibodies in the Roche thyroid-stimulating hormone assay
Buijs, M. M., Gorgels, J. P. M. C., & Endert, E. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010160 · Cited by 33
Partsch, C., Riepe, F. G., Krone, N. P., Sippell, W. G., & Pohlenz, J. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-924232 · Cited by 32
ZWEIG, M. H., Csákó, G., & Spero, M. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.12.2589 · Cited by 31
Furosemide Interference in Newer Free Thyroxine Assays
Hawkins, R. C. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2550 · Cited by 29
Brent, G. A. (2010) · Endocrine updates · doi:10.1007/978-1-4419-1485-9 · Cited by 28
Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients
Verhoye, E., den Bruel, A. V., Delanghe, J., Debruyne, E., & Langlois, M. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.138 · Cited by 28
Ohba, K., Noh, J. Y., Unno, T., Satoh, T., Iwahara, K., Matsushita, A., Sasaki, S., Oki, Y., & Nakamura, H. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0089 · Cited by 28
A Somewhat Bizarre Case of Graves Disease Due to Vitamin Treatment
Al‐Salameh, A., Becquemont, L., Brailly‐Tabard, S., Aubourg, P. R., & Chanson, P. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00054 · Cited by 28
Spuriously High Free Thyroxine Values in Familial Dysalbuminemic Hyperthyroxinemia
Ross, H. A., de Rijke, Y. B., & Sweep, F. C. G. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.158170 · Cited by 27
Falsely Undetectable TSH in a Cohort of South Asian Euthyroid Patients
Drees, J. C., Stone, J. A., Reamer, C. R., Arboleda, V. E., Huang, K., Hrynkow, J., Greene, D. N., Petrie, M. S., Hoke, C., Lorey, T. S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2092 · Cited by 27
Ando, T., Yasui, J., Inokuchi, N., Usa, T., Ashizawa, K., Kamihara, S., & Eguchi, K. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0188 · Cited by 27
Negative Thyrotropin Assay Interference Associated with an IgGκ Paraprotein
Luzzi, V. I., Scott, M. G., & Gronowski, A. M. (2003) · Clinical Chemistry · doi:10.1373/49.4.709 · Cited by 26
Anti-ruthenium antibodies mimic macro-TSH in electrochemiluminescent immunoassay
Gessl, A., Blueml, S., Bieglmayer, C., & Marculescu, R. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0067 · Cited by 26
Sapin, R., Agin, A., & Gasser, F. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.064 · Cited by 25
Unexplained high thyroid stimulating hormone: a “BIG” problem
Mendoza, H., Connacher, A. A., & Srivastava, R. (2009) · BMJ Case Reports · doi:10.1136/bcr.01.2009.1474 · Cited by 25
Anti-streptavidin interferences in Roche thyroid immunoassays: a case report
Peltier, L., Massart, C., Moineau, M., Delhostal, A., & Roudaut, N. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0350 · Cited by 25
Clerico, A., Belloni, L., Carrozza, C., Correale, M., Dittadi, R., Dotti, C., Fortunato, A., Vignati, G., Zucchelli, G. C., & Migliardi, M. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0881 · Cited by 25
Two cases of antiruthenium antibody interference in Modular free thyroxine assay
Heijboer, A. C., IJzerman, R. G., Bouman, A. A., & Blankenstein, M. A. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.008258 · Cited by 24
Biochemical Hyperthyroidism in a Newborn Baby Caused by Assay Interaction from Biotin Intake
Pedersen, I. B., & Laurberg, P. (2016) · European Thyroid Journal · doi:10.1159/000448034 · Cited by 23
Hattori, N., Nakayama, Y., Kitagawa, K., Li, T., & Inagaki, C. (2007) · Endocrinology · doi:10.1210/en.2006-1208 · Cited by 22
Artifactual elevation of thyroid-stimulating hormone
Wood, J. M., Gordon, D. L., Rudinger, A. N., & Brooks, M. M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80170-q · Cited by 22
Interference in free thyroxine immunoassay
Ghosh, S. K., Howlett, M. R., Boag, D. E., Malik, I. A., & Collier, A. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.05.009 · Cited by 22
Euthyroid Patient with Elevated Serum Free Thyroxine
van der Watt, G., Haarburger, D., & Berman, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101428 · Cited by 22
Biotinidase deficiency and our champagne legacy
Wolf, B. (2015) · Gene · doi:10.1016/j.gene.2015.10.010 · Cited by 22
Sapin, R., Gasser, F., & Schlienger, J. L. (2008) · Hormone Research · doi:10.1159/000184776 · Cited by 21
Crinò, A., Borrelli, P., Salvatori, R., CORTELAZZI, D., Roncoroni, R., & Beck‐Peccoz, P. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348675 · Cited by 21
On the interpretation of affirmative follow-up tests in immunoassays: what must not be done?
Ismail, A. A. (2006) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456306777695744 · Cited by 21
When lab tests lie … heterophile antibodies.
Morton, A. (2014) · PubMed · Cited by 21
Interference in thyroid-function tests in postpartum thyroiditis
John, R. M., Othman, S. B., Parkes, A. B., Lazarus, J. H., & Hall, R. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.8.1397 · Cited by 20
Newman, J. D., Bergman, P. B., Doery, J. C. G., & Balazs, N. D. H. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.064832 · Cited by 20
Saleem, M., Lewis, J. G., Florkowski, C. M., Mulligan, G., George, P. M., & Hale, P. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008224 · Cited by 20
Interference in thyroid‐stimulating hormone determination
Imperiali, M., Jelmini, P., Ferraro, B., Keller, F., Bruna, R. D., Balerna, M., & Giovanella, L. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02315.x · Cited by 20
Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests
Favresse, J., Lardinois, B., Nassogne, M., Preumont, V., Maiter, D. M., & Gruson, D. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1027 · Cited by 20
Novel Thyrotropin (TSH)—TSH Antibody Complex in a Healthy Woman and Her Neonates
Tamaki, H., Takeoka, K., NISHI, I., SHINDOH, Y., Tsukada, Y., & Amino, N. (1995) · Thyroid · doi:10.1089/thy.1995.5.299 · Cited by 18
Human anti‐immunoglobulin antibodies interfering in immunometric assays
Bjerner, J. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510025818 · Cited by 18
Increasing frequency and clinical significance of thyroid hormone autoantibodies
Benvenga, S., & Trimarchi, F. (2004) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000137759.57791.f8 · Cited by 18
Interference from heterophilic antibodies in TSH assays
Halsall, D., English, E., & Chatterjee, K. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009024 · Cited by 18
Diagnostic Dilemma In Discordant Thyroid Function Tests Due To Thyroid Hormone Autoantibodies
Srichomkwun, P., Scherberg, N. H., Jakšić, J., & Refetoff, S. (2016) · AACE Clinical Case Reports · doi:10.4158/ep151142.cr · Cited by 18
Falsely raised TSH levels due to human anti-mouse antibody interfering with thyrotropin assay
Krishnan, S. G. S., Pathalapati, R., Kaplan, L. R., & Cobbs, R. (2006) · Postgraduate Medical Journal · doi:10.1136/pmj.2006.049809 · Cited by 17
Interference in thyroid hormones with Roche immunoassays: an unfinished story
Zaninotto, M., Tognon, C., Venturini, R., Betterle, C., & Plebani, M. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0454 · Cited by 17
Biotin supplementation in MS clinically valuable but can alter multiple blood test results
Siddiqui, U., Egnor, E., & Sloane, J. A. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516680751 · Cited by 17
A simple method to detect biotin interference on immunoassays
Lam, L., & Kyle, C. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0059 · Cited by 17
Heterophile Antibody Interference with Thyroid Assay
Chin, K. P., & Pin, Y. C. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1496 · Cited by 15
Massart, C., Elbadii, S., Gibassier, J., Coignard, V., & Rasandratana, A. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.11.001 · Cited by 15
Ranaivosoa, M. K., Ganel, S., Agin, A., Romain, S., Parent, X., & Reix, N. (2017) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2017.02.016 · Cited by 15
Misleading FT4 measurement: Assay-dependent antibody interference
Revet, I. M., Boesten, L. S. M., Linthorst, J., Yildiz, E., Janssen, J. W., de Rijke, Y. B., & Albersen, A. (2016) · Biochemia Medica · doi:10.11613/bm.2016.046 · Cited by 14
First Report of Familial Dysalbuminemic Hyperthyroxinemia With an ALB Variant
Cho, Y. Y., Song, J.-S., Park, H., Kim, Y. N., Kim, H. I., Kim, T. H., Chung, J. H., Ki, C., & Kim, S. W. (2016) · Annals of Laboratory Medicine · doi:10.3343/alm.2017.37.1.63 · Cited by 14
Veljkovic, K., Servedio, D., & Don-Wauchope, A. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011238 · Cited by 13
Massive interference in free T4 and free T3 assays misleading clinical judgment
Favresse, J., Paridaens, H., Pirson, N., Maiter, D. M., & Gruson, D. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0255 · Cited by 13
Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interference
Willeman, T., Casez, O., & Faure, P. (2017) · Revue Neurologique · doi:10.1016/j.neurol.2017.02.009 · Cited by 13
Avoiding Misdiagnosis Due to Antibody Interference with Serum Free Thyroxin
Beato-Víbora, P. I., & Alejo-González, S. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.37792 · Cited by 12
Lee, M.-N., Lee, S., Hur, K. Y., & Park, H. (2016) · Annals of Laboratory Medicine · doi:10.3343/alm.2017.37.2.169 · Cited by 12
Monchamp, T., CHOPRA, I. J., Wah, D. T., & Butch, A. W. (2007) · Thyroid · doi:10.1089/thy.2006.0149 · Cited by 11
A Girl with Goiter and Inappropriate Thyroid-Stimulating Hormone Secretion
Kellogg, M. D., Law, T., Huang, S. A., & Rifai, N. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.102087 · Cited by 11
Utility of dilution tests in investigating interference in the free thyroxine assay
Oostendorp, M., & Lentjes, E. G. W. M. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0140 · Cited by 11
Favresse, J., Bastin, P., Fillée, C., Luyckx, F., Maiter, D. M., & Gruson, D. (2017) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.022632 · Cited by 11
INTERFERBNCE IN MODIFIED IMMUNORADIOMETRIC ASSAY FOR THYROTROPIN
Harvey, R., McHardy, K. C., Trainer, P. J., & Reid, I. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91527-9 · Cited by 10
Iitaka, M., FUKASAWA, N., Hara, Y., Yanagisawa, M., Hase, K., Miura, S., Sakatsume, Y., & Ishii, J. (1990) · European Journal of Endocrinology · doi:10.1530/acta.0.1230123 · Cited by 9
Sugenoya, A., Mizuno, E., Haniuda, M., Fujimori, M., Masuda, H., Kasuga, Y., Kobayashi, S., & Iida, F. (1991) · European Journal of Endocrinology · doi:10.1530/acta.0.1240115 · Cited by 9
Biotin: an emerging analytical interference
Piketty, M., & Souberbielle, J. (2017) · Annales de biologie clinique · doi:10.1684/abc.2017.1252 · Cited by 9
TSH-assay interference: still with us.
Verdickt, L., Maiter, D. M., Depraetere, L., & Gruson, D. (2012) · PubMed · Cited by 8
Sapin, R., Gasser, F., & Chambron, J. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.12.2141 · Cited by 8
Rivero, R. S., Lorenzo, F. P., Torres, J. D., Palomar, J. M. R., & Orozco‐Beltrán, D. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0515 · Cited by 8
Momotani, N., Ito, K., Ohnishi, H., Katsuki, T., & Yamamoto, M. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348708 · Cited by 7
Beda–Maluga, K., Pisarek, H., Komorowski, J., Świętosławski, J., Fuss-Chmielewska, J., & Winczyk, K. (2014) · PubMed · Cited by 7
Implausible elevation of peripheral thyroid hormones during therapy with a protein supplement
Harsch, I. A., Konturek, P. C., Böer, K., & Reinhöfer, M. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-1015 · Cited by 7
A cautionary tale: inappropriate drug treatment after false-positive diagnosis of thyrotoxicosis
Stubbs, P. J., Oppert, S. A., & Collinson, P. O. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.7.1381 · Cited by 7
Interference in assay of free triiodothyronine by triiodothyronine-binding antibodies
Tokmakjian, S., Haines, D. S. M., & Edmonds, M. W. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.12.2150 · Cited by 6
Dellal, F. D., Özdemir, D., Aydın, C., Kaya, G., Ersoy, R., & Çakır, B. (2016) · Case Reports in Endocrinology · doi:10.1155/2016/3576024 · Cited by 6
Response to Heijboer et al. Ann Clin Biochem 2009;46(3):263–4
McKillop, D. J., Thompson, D., & Sharpe, P. C. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009144 · Cited by 4
[Familial dysalbuminemic hyperthyroxinemia].
Hartling, U. B., Nielsen, T. L., & Brøns, M. (2005) · PubMed · Cited by 2
Tourbah, A., & Sedel, F. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516680752 · Cited by 2
Cited by
Sorted by citations
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Lee, S. Y., & Pearce, E. N. (2023) · JAMA · doi:10.1001/jama.2023.19052 · Cited by 364
Nonspecific Binding—Fundamental Concepts and Consequences for Biosensing Applications
Frutiger, A., Tanno, A., Hwu, S., Tiefenauer, R. F., Vörös, J., & Nakatsuka, N. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00044 · Cited by 287
Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis
Wiersinga, W. M., Poppe, K. G., & Effraimidis, G. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00005-0 · Cited by 254
D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications
Favresse, J., Lippi, G., Roy, P., Châtelain, B., Jacqmin, H., Cate, H. T., & Mullier, F. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1529734 · Cited by 222
Metadata
- Authors
- Favresse, J., Burlacu, M.-C., Maiter, D., & Gruson, D.
- Affiliations
- Cliniques Universitaires Saint-Luc (BE)
- Corresponding author
- Gruson, Damien
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2018-07-04
- Volume
- 39
- Issue
- 5
- Pages
- 830-850
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2894797166
- Cited by
- 258
- References
- 158
- Citations by year
- 2026: 33 · 2025: 27 · 2024: 20 · 2023: 47 · 2022: 35 · 2021: 36 · 2020: 37 · 2019: 21 · 2018: 2
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
- Funders
- Université Catholique de Louvain
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- thyroid function tests, immunoassay interference, thyroid-stimulating hormone, free thyroxine, free triiodothyronine, biotin interference, heterophile antibodies, detection algorithm, misdiagnosis, inappropriate treatment
- MeSH terms
- Algorithms, Humans, Immunoassay, Sensitivity and Specificity, Thyroid Function Tests, Thyrotropin, Thyroxine, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
